- Home
- WES vs NBIX Comparison
WES vs NBIX Comparison
Compare WES & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WES | NBIX |
|---|---|---|
| Founded | 2007 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 14.4B |
| IPO Year | 2008 | 1996 |
Fundamental Metrics
Financial Performance| Metric | WES | NBIX |
|---|---|---|
| Price | $40.05 | $155.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 19 |
| Target Price | $41.20 | ★ $173.79 |
| AVG Volume (30 Days) | ★ 1.6M | 969.9K |
| Earning Date | 11-04-2025 | 10-28-2025 |
| Dividend Yield | ★ 9.10% | N/A |
| EPS Growth | N/A | ★ 12.44 |
| EPS | 3.38 | ★ 4.19 |
| Revenue | ★ $3,740,425,000.00 | $2,682,700,000.00 |
| Revenue This Year | $8.40 | $23.76 |
| Revenue Next Year | $6.96 | $18.01 |
| P/E Ratio | ★ $11.83 | $37.10 |
| Revenue Growth | 5.81 | ★ 19.61 |
| 52 Week Low | $33.60 | $84.23 |
| 52 Week High | $43.33 | $157.67 |
Technical Indicators
Market Signals| Indicator | WES | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 60.21 | 64.81 |
| Support Level | $38.79 | $150.26 |
| Resistance Level | $39.73 | $154.35 |
| Average True Range (ATR) | 0.62 | 4.16 |
| MACD | 0.09 | 1.07 |
| Stochastic Oscillator | 67.52 | 93.25 |
Price Performance
Historical ComparisonAbout WES Western Midstream Partners LP Common Units Representing Limited Partner Interests
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.